Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04822688 · ClinicalTrials.gov registry record
Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues
A clinical trial, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- 141
- Enrollment target
NCT04822688 is a clinical trial that has completed, run by Thomas Jefferson University. The registered enrollment target is 141 participants.
The verdict
NCT04822688 has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- 141 participants
- Enrollment target
Study Summary
This study examines tumor tissues and blood samples to aid in the development of therapies for brain cancer and other solid tumors. Studying samples of blood and tissue from patients with glioblastoma or other solid tumor in the laboratory may help doctors understand brain tumors and better inform future treatments.
Interventions
- PROCEDURE Biospecimen Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2021-02-03 |
| Est. Completion | 2025-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04822688
The ClinicalTrials.gov registry entry for NCT04822688 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 141 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Biospecimen Collection is the first listed.
NCT04822688 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04822688 about?
NCT04822688 is a clinical study titled "Analysis of Cell Count, Viability, and Immunogenicity of Discarded Newly Diagnosed Glioblastoma Tissue or Solid Tumor Tissues". This study examines tumor tissues and blood samples to aid in the development of therapies for brain cancer and other solid tumors. Studying samples of blood and tissue from patients with glioblastoma or other solid tumor in the laboratory may help doctors understand brain tumors and better inform f...
What is the current status of trial NCT04822688?
This trial is currently completed. The enrollment target is 141 participants. The study started on 2021-02-03. Estimated completion is 2025-06-30.
What interventions are being tested in trial NCT04822688?
The interventions under investigation include: Biospecimen Collection (PROCEDURE).
Who is sponsoring clinical trial NCT04822688?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.